Global Vitreoretinal Surgery Devices Market by Types (Photocoagulation Surgery Devices, Vitrectomy Surgery Devices, Illumination Surgery Devices), by End Users (Private Eye Clinics & Hospitals) & by Geography - Analysis & Forecast to 2019

The demand for vitreoretinal surgeries has increased significantly over the years mainly due to rising incidences of eye diseases. Vitreoretinal surgery devices are used in the treatment of detached eye retinas. The retina is a crucial and extremely sensitive part of the human eye and is made up of various tissue layers. These tissue layers can be damaged due to various factors, including age-related damage, muscular holes, or severe eye injuries. In accordance with a study conducted by PubMed, it has been found that retinal detachment comprises nearly 5.8% of the total number of cases of vitreoretinal diseases. Moreover, since vitreoretinal diseases are found to be more common in male patients aged 40 years and above, the growing aging population has resulted in an increase in prevalence of these diseases in recent years.

The global vitreoretinal surgery device market is segmented into various sub-types, including photocoagulation surgery devices, vitrectomy surgery devices, and illumination surgery devices. Among all the types, the photocoagulation surgery devices segment holds the highest market share of 52.4% followed by the vitrectomy devices segment having a market share of 35.2% of the whole market.

The global vitreoretinal surgery devices market is estimated to grow at a CAGR of 8.9% in the period of 2014 to 2019. Various technological advancements in the medical field, increasing aging population, and the rise in the number of retinopathies has provided a wide range of growth opportunities for the market.

On the basis of geography, North America and Europe command the largest shares of the global market. Owing to the increasing number of eye-related diseases, there has been a growth trend in these regions in the past few years.

In-depth market share analysis, by revenue, of the top companies is also included in the report. These numbers are arrived at, based on key facts, annual financial information from SEC filings, annual reports and interviews with industry experts, key opinion leaders such as CEOs, directors, and marketing executives. Detailed market share analysis of the major players in the global vitreoretinal surgery devices market is also covered in this report.

The key players in the global vitreoretinal surgery devices market are Abbott Laboratories (U.S.), Alcon, Inc. (Switzerland), Carl Zeiss Meditec AG (Germany), and Nidek Co., Ltd. (U.S.).

Table of Contents

1 Introduction (Page No. - 10)
    1.1 Objectives of the Study
    1.2 Market Segmentation & Coverage
    1.3 Stakeholders

2 Research Methodology (Page No. - 12)
    2.1 Integrated Ecosystem of the Vitreoretinal Surgery Devices Market
           2.1.1 Top-Down Approach
           2.1.2 Bottom-Up Approach
           2.1.3 Demand-Side Approach
           2.1.4 Macroindicator-Based Approach
    2.2 Assumptions

3 Executive Summary (Page No. - 20)

4 Market Overview (Page No. - 22)
    4.1 Introduction
    4.2 Vitreoretinal Surgery Devices: Comparison With Parent Market (Ophthalmology Surgery Devices)
    4.3 Market Drivers and Inhibitors
    4.4 Key Market Dynamics

5 Global Vitreoretinal Surgery Devices Market, By Type (Page No. - 28)
    5.1 Introduction
    5.2 Global Vitreoretinal Surgery Devices Market: Type Comparison With Parent Market (Ophthalmology Surgery Devices Market)
    5.3 Global Photocoagulation Vitreoretinal Surgery Devices Market, By Geography
    5.4 Global Vitrectomy Vitreoretinal Surgery Devices Market, By Geography
    5.5 Global Illumination Vitreoretinal Surgery Devices Market, By Geography

6 Global Vitreoretinal Surgery Devices Market, By End User (Page No. - 34)
    6.1 Introduction
    6.2 Market for Private Eye Clinics, By Geography
    6.3 Market for Hospitals, By Geography
    6.4 Market for Others, By Geography

7 Global Vitreoretinal Surgery Devices Market, By Geography (Page No. - 39)
    7.1 Introduction
    7.2 North America Vitreoretinal Surgery Devices Market
           7.2.1 North American Vitreoretinal Surgery Devices Market, By End User
           7.2.2 North America: Vitreoretinal Surgery Devices Market, By Type
    7.3 Europe: Vitreoretinal Surgery Devices Market
           7.3.1 Europe: Vitreoretinal Surgery Devices Market, By End User
           7.3.2 Europe Vitreoretinal Surgery Devices Market, By Type
    7.4 Asia: Vitreoretinal Surgery Devices Market
           7.4.1 Asian Vitreoretinal Surgery Devices Market, By End User
           7.4.2 Asian Vitreoretinal Surgery Devices Market, By Type
    7.5 RoW Vitreoretinal Surgery Devices Market
           7.5.1 RoW Vitreoretinal Surgery Devices Market, By End User
           7.5.2 RoW Vitreoretinal Surgery Devices Market, By Type

8 Vitreoretinal Surgery Devices Market: Competitive Landscape (Page No. - 54)
    8.1 Company Share Analysis
    8.2 Mergers & Acquisitions
    8.3 Agreements/Partnerships/Collaborations
    8.4 New Technology/Product Development

9 Global Vitreoretinal Surgery Devices Market, By Company (Page No. - 58)
(Overview, Financials, Products & Services, Strategy, and Developments)*
    9.1 Abbott Laboratories
    9.2 Alcon, Inc. (Subsidiary of Novartis Ag)
    9.3 Allergan, Inc.
    9.4 Bausch & Lomb, Inc.
    9.5 Carl Zeiss Meditech Ag
    9.6 Essilor International S.A.
    9.7 Nidek Co., Limited
    9.8 Topcon Corporation
*Details On Overview, Financials, Product & Services, Strategy, and Developments Might Not Be Captured in Case of Unlisted Company

10 Appendix (Page No. - 77)
     10.1 Customization Options
             10.1.1 Product Analysis
             10.1.2 Surgeon/Physician Perception Analysis
             10.1.3 Brand/Product Perception Matrix
     10.2 Related Reports
     10.3 Introducing Rt: Real-Time Market Intelligence
             10.3.1 Rt Snapshots

List of Tables (32 Tables)

Table 1 Vitreoretinal Surgery Devices Applications Market (Aging Population),By Geography, 2014 (Bn)
Table 2 Vitreoretinal Surgery Devices Market: Macroindicators, By Geography, 2014 (USD MN)
Table 3 Vitreoretinal Surgery Devices Market: Comparison With Parent Market (Ophthalmology Surgery Devices Market), 2013 – 2019 (USD MN)
Table 4 Vitreoretinal Surgery Devices Market: Drivers and Inhibitors
Table 5 Global Vitreoretinal Surgery Devices Market, By End User,2013 – 2019 (USD MN)
Table 6 Global Vitreoretinal Surgery Devices Market, By Type,  2013 – 2019 (USD MN)
Table 7 Global Vitreoretinal Surgery Devices Market, By Geography,2013 – 2019 (USD MN)
Table 8 Global Vitreoretinal Surgery Devices Market, By Type, 2013 – 2019 (USD MN)
Table 9 Global Vitreoretinal Surgery Devices Market: Type Comparison With Parent Market (Ophthalmology Surgery Devices), 2013 – 2019 (USD MN)
Table 10 Global Photocoagulation Vitreoretinal Surgery Devices Market,By Geography, 2013 – 2019 (USD MN)
Table 11 Global Vitrectomy Vitreoretinal Surgery Devices Market, By Geography, 2013 – 2019 (USD MN)
Table 12 Global Illumination Vitreoretinal Surgery Devices Market, By Geography, 2013 – 2019 (USD MN)
Table 13 Global Vitreoretinal Surgery Devices Market, By End User,2013 – 2019 (USD MN)
Table 14 Global Vitreoretinal Surgery Devices Market for Private Eye Clinics,By Geography, 2013 – 2019 (USD MN)
Table 15 Global Vitreoretinal Surgery Devices Market for Hospitals, By Geography, 2013 – 2019 (USD MN)
Table 16 Global Vitreoretinal Surgery Devices Market for Others, By Geography, 2013 – 2019 (USD MN)
Table 17 Global Vitreoretinal Surgery Devices Market, By Geography,2013 – 2019 (USD MN)
Table 18 North America: Vitreoretinal Surgery Devices Market, By End User,2013 – 2019 (USD MN)
Table 19 North America: Vitreoretinal Surgery Devices Market, By Type,2013 – 2019 (USD MN)
Table 20 Europe: Vitreoretinal Surgery Devices Market, By End User,2013 – 2019 (USD MN)
Table 21 Europe: Vitreoretinal Surgery Devices Market, By Type, 2013 – 2019 (USD MN)
Table 22 Asia: Vitreoretinal Surgery Devices Market, By End User,2013 – 2019 (USD MN)
Table 23 Asia: Vitreoretinal Surgery Devices Market, By Type, 2013 – 2019 (USD MN)
Table 24 RoW: Vitreoretinal Surgery Devices Market, By End User,2013 – 2019 (USD MN)
Table 25 RoW: Vitreoretinal Surgery Devices Market, By Type, 2013 – 2019 (USD MN)
Table 26 Company Share Analysis, 2013 (%)
Table 27 Mergers & Acquisitions
Table 28 Agreements/Partnerships/Collaborations
Table 29 New Technology/Product Development
Table 30 Abbott Laboratories: Key Financials, 2009 – 2013 (USD MN)
Table 31 Allergan, Inc.: Key Operations Data, 2009 – 2013 (USD MN)
Table 32 Essilor International S.A.: Key Financials, 2008 - 2013 (USD MN)

List of Figures (37 Figures)

Figure 1 Segmentation & Coverage
Figure 2 Vitreoretinal Surgery Devices Market: Integrated Ecosystem
Figure 3 Top-Down Approach
Figure 4 Bottom-Up Approach
Figure 5 Demand-Side Approach
Figure 6 Macroindicator-Based Approach
Figure 7 Global Vitreoretinal Surgery Devices Market Snapshot
Figure 8 Vitreoretinal Surgery Devices Market: Growth Aspects
Figure 9 Global Vitreoretinal Surgery Devices Market, By End User, 2014
Figure 10 Global Vitreoretinal Surgery Devices Market, By Geography,  2014 (USD MN)
Figure 11 Global Vitreoretinal Surgery Devices Market, By Type, 2013 – 2019 (USD MN)
Figure 12 Global Vitreoretinal Surgery Devices Market: Type Comparison With Parent Market (Ophthalmology Surgery Devices Market),2013 – 2019 (USD MN)
Figure 13 Global Photocoagulation Vitreoretinal Surgery Devices Market,By Geography, 2013 – 2019 (USD MN)
Figure 14 Global Vitrectomy Vitreoretinal Surgery Devices Market, By Geography, 2013 – 2019 (USD MN)
Figure 15 Global Illumination Vitreoretinal Surgery Devices Market, By Geography, 2013 – 2019 (USD MN)
Figure 16 Global Vitreoretinal Surgery Devices Market, By End User,2014 – 2019 (USD MN)
Figure 17 Global Vitreoretinal Surgery Devices Market for Private Eye Clinics,By Geography, 2013 – 2019 (USD MN)
Figure 18 Global Vitreoretinal Surgery Devices Market for Hospitals, By Geography, 2013 – 2019 (USD MN)
Figure 19 Global Vitreoretinal Surgery Devices Market for Others, By Geography, 2013 – 2019 (USD MN)
Figure 20 Global Vitreoretinal Surgery Devices Market: Growth Analysis,By Geography, 2013 – 2019 (USD MN)
Figure 21 North America: Vitreoretinal Surgery Devices Market Overview,2014 & 2019 (%)
Figure 22 North America: Vitreoretinal Surgery Devices Market, By End User,2013 – 2019 (USD MN)
Figure 23 North America: Vitreoretinal Surgery Devices Market, By End User Snapshot
Figure 24 North America: Vitreoretinal Surgery Devices Market, By Type,2013 – 2019 (USD MN)
Figure 25 Europe: Vitreoretinal Surgery Devices Market Overview, 2014 & 2019 (%)
Figure 26 Europe: Vitreoretinal Surgery Devices Market, By End User,2013 – 2019 (USD MN)
Figure 27 European Vitreoretinal Surgery Devices Market: End Users Snapshot
Figure 28 Europe: Vitreoretinal Surgery Devices Market, By Type, 2013 – 2019 (USD MN)
Figure 29 Asia: Vitreoretinal Surgery Devices Market Overview, 2014 & 2019 (%)
Figure 30 Asia: Vitreoretinal Surgery Devices Market, By End User,2013 – 2019 (USD MN)
Figure 31 Asian Vitreoretinal Surgery Devices Market: End User Snapshot
Figure 32 Asia: Vitreoretinal Surgery Devices Market, By Type, 2013 – 2019 (USD MN)
Figure 33 RoW: Vitreoretinal Surgery Devices Market Overview, 2014 & 2019 (%)
Figure 34 RoW: Vitreoretinal Surgery Devices Market, By End User,2013 – 2019 (USD MN)
Figure 35 RoW Vitreoretinal Surgery Devices Market: End-User Snapshot
Figure 36 RoW Vitreoretinal Surgery Devices Market, By Type, 2013 – 2019 (USD MN)
Figure 37 Company Share Analysis, 20134 (%)

Vitreoretinal surgery devices are used in the treatment of detached eye retinas. The retina is a crucial and extremely sensitive part of the human eye and is made up of various tissue layers. These tissue layers can be damaged due to various factors, including age-related damage, muscular tears, or severe eye injuries. In accordance with a study conducted by PubMed, it has been found that retinal detachment comprises nearly 5.8% of the total number of cases of vitreoretinal diseases. Moreover, since vitreoretinal diseases are found to be more common in male patients aged 40 years and above, the growing aging population has resulted in an increase in prevalence of these diseases in recent years.

The vitreoretinal surgery devices market has continued to remain robust across all regions. This can largely be attributed to the rising number of diseases associated with the eyes in recent years. In addition to this, rising disposable incomes across the globe have made treatments more affordable. Besides this, the rise in the aging population and the increasing number of retinopathies are also responsible for the growth of the market.

The vitreoretinal surgery devices market constitutes 9.0% of the global ophthalmology surgery devices market and is growing at a CAGR of 8.9% from 2014 to 2019.

Based on type, the global vitreoretinal surgery devices market is classified into three types—photocoagulation surgery devices, vitrectomy surgery devices, and illumination surgery devices. The end users consist of hospitals and private eye clinics. Among the types, the photocoagulation surgery devices segment commanded the largest share of 52.4% of the global vitreoretinal surgery devices market. However, illumination surgery devices were the fastest-growing segment amongst all its types. It recorded a CAGR of 9.4% during the forecasted period of 2014 to 2019.

The global vitreoretinal surgery devices market is further segmented and forecasted on the basis of major regions, such as North America, Europe, Asia-Pacific, and the Rest of the World. Amongst all, North America accounted for the largest share of 39.31% in 2014 with a revenue of $260.7 million, growing at a CAGR of 4.3% in the forecast period of 2014 to 2019.

The key players in the global Vitreoretinal surgery devices market are Abbott Laboratories (U.S.), Alcon, Inc. (Switzerland), Carl Zeiss Meditec AG (Germany), and Nidek Co.